Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Claims To Be Held Once Again
Roberta Buell, MBA, Sausalito Healthcare Partners
The Best of 2009
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all

Articles: Myeloproliferative Dz



Latest (2) Month's Top Read Top 50 of Year  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
Leukemia, 01/09/09
Sponsor
Insulin-like Growth Factor-1- and Interleukin-6-related Gene Variation and Risk of Multiple Myeloma
Cancer Epidemiology, Biomarkers & Prevention, 01/08/09
Phosphoinositide-phospholipase c β1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia
Journal of Clinical Oncology, 01/07/09    Evidence Based Medicine
WHIM syndrome: congenital immune deficiency disease
Current Opinion in Hematology, 01/07/09
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens
Cancer, 01/06/09
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype
Blood, 01/06/09    Evidence Based Medicine
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma
Experimental Hematology, 01/05/09
Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis
Experimental Hematology, 01/05/09
An update on the diagnosis and management of PNH
Myeloproliferative Disorders in practice, 12/31/08
Juvenile myelomonocytic leukaemia - an update
Myeloproliferative Disorders in practice, 12/31/08
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes
Journal of Clinical Oncology, 12/30/08    Evidence Based Medicine
Inhibition of the Bcl-XL deamidation pathway in myeloproliferative disorders
New England Journal of Medicine, 12/30/08
Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology, 12/30/08
Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders
Blood Cells, Molecules, and Diseases, 12/30/08
Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia
Leukemia Research, 12/30/08
Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes
Leukemia Research, 12/30/08
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
Leukemia Research, 12/30/08
Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
Leukemia Research, 12/23/08
Are new agents really making a difference in MDS
Best Practice & Research: Clinical Haematology, 12/18/08
Tumor suppressor gene inactivation in myeloid malignancies
Best Practice & Research: Clinical Haematology, 12/18/08

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
125 Available Pages
First    Prev    22      23      24      25      26      27      28      29      30      31      Next      Last
 
 

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
 

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
 
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2010 M3 USA